Publication | Open Access

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Hepatitis DHepatologyViral HepatitisPharmacologyHepatitis BHepatitisOral Prenylation InhibitionAntiviral TherapyPharmacotherapyPlacebo-controlled Phase 2ALiver DiseaseAntiviral DrugMedicine